首页> 外文期刊>European journal of gynaecological oncology >Borderline ovarian tumors: Outcomes of fertility sparing surgery
【24h】

Borderline ovarian tumors: Outcomes of fertility sparing surgery

机译:卵巢交界性肿瘤:保留生育力的手术结果

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Borderline ovarian tumors(BOT) account for ten to 20 percent of all epitelial ovarian carcinomas and often occur in reproductive ages. The aim of this study was to evaluate the clinical and reproductive outcomes of patients who were diagnosed with BOT and underwent fertility sparing surgery. Materials and Methods: Patients younger than 40 years who underwent fertility sparing surgery for BOT from 2004 to 2012 were reviewed retrospectively and were evaluated according to the reproductive and clinical outcomes. Results: Twenty-eight patients younger than 40 years with BOT underwent fertility sparing surgery. Median follow up time was 42 ± 28.1 months. During the follow up period, two patients (7.1%) developed recurrence at 35 and 36 months, respectively. Five (17.9%) out of 28 patients became pregnant during the follow up period. Conclusion: Fertility sparing surgery should be the first choice for the treatment of BOT in patients who wish to preserve fertility.
机译:目的:交界性卵巢肿瘤(BOT)占所有上皮性卵巢癌的10%至20%,通常发生在生殖年龄。这项研究的目的是评估诊断为BOT并进行了节育手术的患者的临床和生殖结果。材料与方法:回顾性分析2004年至2012年接受BOT生育保留手术的40岁以下患者,并根据其生殖和临床结局进行评估。结果:28名年龄小于40岁的BOT患者接受了保留生育的手术。中位随访时间为42±28.1个月。在随访期间,两名患者(7.1%)分别在35个月和36个月出现复发。 28名患者中有5名(17.9%)在随访期间怀孕。结论:保留生育力的患者应首选保留生育力的手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号